ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

In Brief: Appelbaum Clinical Dib. At Hutchinson; Vogelstein Win Pezcoller Award; Curiel To UAB

July 23, 1993

AIDS Commission Asks, “Give Us A Chance”

September 18, 1987

Sloan-Kettering Cited For 8 Violations Of NY State Standards

November 24, 1995

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

Changes In Cooperative Groups As Result Of Move To DCT Topic Of Chairmen’s Meeting Sept. 16

August 22, 1975